Rachel Hibbs (Consultant – Systematic Review) tells us about her career to date and what inspired her to join Mtech Access.
Read More
What actions can you take in light of ISPOR’s top 10 HEOR trends? What impact may these issues have on your HEOR and Market Access strategy?
We are delighted to announce that Mtech Access are now a certified NICE Medtech Early Technical Assessment (META) Tool facilitating organisation. Samantha Gillard (Director – HTA), Persefoni Ioannou (Consultant –...
Read More
Specialised Commissioning continues to be an issue of significance and uncertainty for both industry and the NHS. What do the latest reports of regional push back on the plans for devolution to ICBs mean?
Ahead of our NHS Transformation Symposium, former Pharma UK Market Access Director, Richard Marsh offers his thoughts on transforming the NHS.
How is the UK political landscape evolving and what does this mean for Health Technology and Medical Device innovators? On Friday 28th July, Robert Hull (Senior Consultant – NHS Insight...
Read More
Building strategic engagement with a changing NHS We invited strategic UK market access and commercialisation teams to join us and our guest speakers for our NHS Transformation Symposium on Tuesday...
Read More
As our developers experiment with integrating AI into our tools, we demonstrate the potential (and current limitations) of this technology with ChatGPT
Visit our virtual booth We are delighted to announce that we will be exhibiting at The MedTech Forum on 30th May – 1st June in Dublin. The event is MedTech...
Read More
How and where can innovation drive improvements in care and deliver better health for the population? How is the NHS looking to collaborate with key partners across industry and academia?...
Read More
